Subject of the day
ADMA
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
FY 2012–2025 · 14 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $258.21M | +56.6% | |
| Gross profit | $292.76M | +87.2% | |
| Operating income | $191.44M | — | |
| Net income | $146.93M | -25.7% | |
| Cash from ops | $8.80M | — |
$9.41
▼ -0.37 (-3.8%)
| 52w hi | $20.38 |
|---|---|
| 52w lo | $7.60 |
| Vol | 3.06M |
| As of | Aug 13 |
Our score -0.25
| Short | -0.78 |
|---|---|
| Medium | -0.09 |
| Long | +0.47 |
computed 2026-08-13
ADMA Biologics, Inc.
Healthcare · Biotechnology
| Market cap | $2.11B |
|---|---|
| Enterprise value | $43.94B |
| Trailing P/E | 13.44x |
| Forward P/E | 9.58x |
| EV / EBITDA | 195.98x |
| P / S (ttm) | 4.11x |
| Profit margin | 33.0% |
| Return on equity | 41.9% |
| Revenue growth | +15.9% |
| Earnings growth | — |
| Debt / equity | 110.67 |
| Beta vs SPX | 1.16 |
|---|---|
| Corr SPX | 0.31 |
| Annual vol | 61.2% |
| Annual ret | +5.5% |
| Sharpe | 0.09 |
| Max DD | -69.0% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.35 | |
| Sector | +0.14 | |
| Technical | -0.34 | |
| Earnings | +0.00 | |
| Sentiment | -0.14 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $9.85 | $9.86 | $9.24 | $9.41 | 3.06M |
| Aug 12 | $9.83 | $9.96 | $9.76 | $9.78 | 1.92M |
| Aug 11 | $9.88 | $10.01 | $9.73 | $9.90 | 2.54M |
| Aug 10 | $9.79 | $10.06 | $9.70 | $9.75 | 1.90M |
| Aug 7 | $9.97 | $10.19 | $9.75 | $9.90 | 3.31M |